Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Faivre

Showing results (71-80 of 139) with videos related to

Pageof 14
Sort By:
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|December 7, 2025
Simultaneous Head and Neck and Lung Cancers: Implications and Therapeutic Management TimingDario Ebode, France Truong, Caroline Halimi, et al.
Journal of the National Cancer Institute|March 26, 2009
Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservationYoann Pointreau, Pascal Garaud, Sophie Chapet, et al.
American Journal of Clinical Oncology|August 19, 2009
Reports of clinical benefit of plitidepsin (Aplidine), a new marine-derived anticancer agent, in patients with advanced medullary thyroid carcinomaChristophe Le Tourneau, Sandrine Faivre, Eva Ciruelos, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2004
Locoregional effects of pegylated liposomal doxorubicin (Caelyx) in irradiated area: a phase I-II study in patients with recurrent squamous cell carcinoma of the head and neckSandrine Faivre, Hassan Alsabe, Latifa Djafari, et al.
Marine Drugs|March 23, 2013
Predictive factors of sensitivity to elisidepsin, a novel Kahalalide F-derived marine compoundMaria Serova, Armand de Gramont, Ivan Bieche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2004
Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancerEric Raymond, Jérôme Alexandre, Sandrine Faivre, et al.
The Oncologist|March 22, 2014
Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenibMaxime Ronot, Mohamed Bouattour, Johanna Wassermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Dosage adjustment and pharmacokinetic profile of irinotecan in cancer patients with hepatic dysfunctionEric Raymond, Valérie Boige, Sandrine Faivre, et al.
Oral Oncology|January 9, 2019
Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapyDiane Evrard, Petr Szturz, Annemilaï Tijeras-Raballand, et al.
Neuroendocrinology|June 13, 2009
Temozolomide: a safe and effective treatment for malignant digestive endocrine tumorsFrédérique Maire, Pascal Hammel, Sandrine Faivre, et al.
Pageof 14

Showing results (71-80 of 139) with videos related to

Sort By:
Pageof 14
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|December 7, 2025
Simultaneous Head and Neck and Lung Cancers: Implications and Therapeutic Management TimingDario Ebode, France Truong, Caroline Halimi, et al.
Journal of the National Cancer Institute|March 26, 2009
Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservationYoann Pointreau, Pascal Garaud, Sophie Chapet, et al.
American Journal of Clinical Oncology|August 19, 2009
Reports of clinical benefit of plitidepsin (Aplidine), a new marine-derived anticancer agent, in patients with advanced medullary thyroid carcinomaChristophe Le Tourneau, Sandrine Faivre, Eva Ciruelos, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2004
Locoregional effects of pegylated liposomal doxorubicin (Caelyx) in irradiated area: a phase I-II study in patients with recurrent squamous cell carcinoma of the head and neckSandrine Faivre, Hassan Alsabe, Latifa Djafari, et al.
Marine Drugs|March 23, 2013
Predictive factors of sensitivity to elisidepsin, a novel Kahalalide F-derived marine compoundMaria Serova, Armand de Gramont, Ivan Bieche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2004
Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancerEric Raymond, Jérôme Alexandre, Sandrine Faivre, et al.
The Oncologist|March 22, 2014
Alternative Response Criteria (Choi, European association for the study of the liver, and modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in patients with advanced hepatocellular carcinoma treated with sorafenibMaxime Ronot, Mohamed Bouattour, Johanna Wassermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Dosage adjustment and pharmacokinetic profile of irinotecan in cancer patients with hepatic dysfunctionEric Raymond, Valérie Boige, Sandrine Faivre, et al.
Oral Oncology|January 9, 2019
Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapyDiane Evrard, Petr Szturz, Annemilaï Tijeras-Raballand, et al.
Neuroendocrinology|June 13, 2009
Temozolomide: a safe and effective treatment for malignant digestive endocrine tumorsFrédérique Maire, Pascal Hammel, Sandrine Faivre, et al.
Pageof 14